Cytek Biosciences Inc (CTKB)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|
| Operating income | US$ in thousands | -27,845 | -1,804 | 9,157 |
| Revenue | US$ in thousands | 193,015 | 2,963 | 2,181 |
| Operating profit margin | -14.43% | -60.88% | 419.85% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $-27,845K ÷ $193,015K
= -14.43%
Cytek Biosciences Inc's operating profit margin has shown significant variability over the past three years. In 2021, the company reported an exceptionally high operating profit margin of 419.85%, indicating strong profitability from its core operations. However, there was a substantial decline in 2022, with the operating profit margin plummeting to -60.88%, suggesting a significant decrease in profitability and potential operating inefficiencies.
In the most recent year, 2023, Cytek Biosciences Inc continued to face challenges as the operating profit margin remained negative at -14.43%. This negative operating profit margin may indicate that the company's operating expenses were high relative to its revenue, leading to a loss from its core business activities.
Overall, the fluctuating trend in operating profit margin raises concerns about Cytek Biosciences Inc's ability to effectively manage its operating costs and generate profits from its primary operations. Further analysis of the company's cost structure and revenue-generating strategies may be necessary to address the declining profitability trend.
Peer comparison
Dec 31, 2023